← Back to all trials
Completed
NCT05650944
How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?
Conditions: COVID-19
Sex: All
Ages: 18 Years – N/A
Enrollment: 125
Sponsor: Hisar Intercontinental Hospital
Location: Turkey
Summary
It is aimed to reveal the treatment and prognostic values by evaluating the differences in hematological parameters and indices, especially in dead Covid-19 cases.Material Method: It is planned to retrospectively examine the hemogram parameters of 125 male, 44 female and 169 critical Covid-19 patients hospitalized between 01.03.2020 and 31.12.2021.
Subjects were divided into 2 groups as deceased (77) and living (92) patients according to demographic data such as age and gender.Statistical evaluation: All analyzes were SPSS 25.0, Kolmogorov Smirnov test was used to determine distribution, median and interquartile range (Tukey's Hinges Percentile) were used to summarize variables.
The differences between the Independent-Samples Mann Whitney U Test and the data of the patient groups and the optimal cut-off values, sensitivity and specificity values will be determined by ROC analysis.
It will be considered statistically significant when the p value is below 0.05 (with the two-tailed test)
Eligibility Criteria
Inclusion Criteria:Patients over the age of 18Critical patients taken to intensive careThe length of stay in the ICU is more than 24 hoursExclusion Criteria:1) Patients under 18 years of age (2) Patients with hematological malignancies (3) The length of stay in the ICU is less than 24 hours.
Source: ClinicalTrials.gov (NCT05650944). StuddyBuddy aggregates publicly available trial information.
